Literature DB >> 25471297

Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases.

Marine Cavalié1, Laura Sillard, Henri Montaudié, Philippe Bahadoran, Jean-Philippe Lacour, Thierry Passeron.   

Abstract

Topical or intralesional corticosteroids are referred to as gold standard treatments for keloids. Recent studies showed that ablative fractional laser (AFL) treatment facilitates delivery of topical drug deeply into the skin by creating vertical channels. The objective of the present study was to assess the ablative erbium laser in fractionated mode, combined with topical high potent corticosteroid cream for treating resistant keloid scars. We conducted a retrospective study in the laser center of the Department of Dermatology (University Hospital of Nice, France), from January 2010 to June 2012, on patients with keloids who were resistant to a first-line of treatment. A 2940-nm ablative fractional erbium laser was used. Topical betamethasone cream was applied twice a day under occlusion with transparent film dressings. A total of 23 patients with 70 keloids were treated from January 2010 to June 2012. The median percentage of improvement was 50% (range -43 to 84). The mean follow-up was 8 months (range 3-18), and a recurrence was observed for eight lesions (22%). Although this observation warrants a prospective comparative evaluation, it supports the interest of the laser-assisted delivery of steroids for treating keloids scars.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ablative fractional laser; keloid treatment; laser-assisted drug delivery; topical corticosteroids; transepidermal drug delivery

Mesh:

Substances:

Year:  2014        PMID: 25471297     DOI: 10.1111/dth.12187

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  16 in total

Review 1.  Emerging Therapies for Scar Prevention.

Authors:  Lisa Block; Ankush Gosain; Timothy W King
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-10-01       Impact factor: 4.730

Review 2.  Laser-assisted drug delivery in dermatology: from animal models to clinical practice.

Authors:  Faisal R Ali; Firas Al-Niaimi
Journal:  Lasers Med Sci       Date:  2015-12-22       Impact factor: 3.161

3.  Evaluation of nonablative fractional laser treatment in scar reduction.

Authors:  Hilal Gokalp
Journal:  Lasers Med Sci       Date:  2017-08-12       Impact factor: 3.161

Review 4.  Treatment of keloid scars using light-, laser- and energy-based devices: a contemporary review of the literature.

Authors:  E Forbat; F R Ali; F Al-Niaimi
Journal:  Lasers Med Sci       Date:  2017-10-18       Impact factor: 3.161

5.  Comparison of Intralesional Triamcinolone Acetonide, 5-Fluorouracil, and Their Combination for the Treatment of Keloids.

Authors:  Sunil Srivastava; Aditya Nanasaheb Patil; Chaitra Prakash; Hiranmayi Kumari
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-11-01       Impact factor: 4.730

6.  Evaluating the Efficacy of the Er,Cr:YSGG Fractional Laser Before Treatment With Triamcinolone NN Ointment in Oral Lichen Planus Lesions.

Authors:  Hamid Reza Khalighi; Fahimeh Anbari; Seyed Masoud Mojahedi; Gelareh Forouzani
Journal:  J Lasers Med Sci       Date:  2022-05-21

7.  Efficacy and safety of laser combination therapy and laser alone therapy for keloid: a systematic review and meta-analysis.

Authors:  Jiahui Chen; Aiyue Chen; Jianhao Zhang; Feipeng Wang; Qiongfang Fang; Ziwei He; Xi Chen; Wancheng Ma; Fulan Hu
Journal:  Lasers Med Sci       Date:  2021-07-20       Impact factor: 3.161

8.  Hypertrophic Scar Outcomes in Fractional Laser Monotherapy Versus Fractional Laser-Assisted Topical Corticosteroid Delivery: A Randomized Clinical Trial.

Authors:  Woraphong Manuskiatti; Arisa Kaewkes; Chadakan Yan; Janice Natasha Ng; Joshua Zev Glahn; Rungsima Wanitphakdeedecha
Journal:  Acta Derm Venereol       Date:  2021-03-17       Impact factor: 3.875

9.  Bleomycin administered by laser-assisted drug delivery or intradermal needle-injection results in distinct biodistribution patterns in skin: in vivo investigations with mass spectrometry imaging.

Authors:  Kristoffer Hendel; Anders C N Hansen; Liora Bik; Charlotte Bagger; Martijn B A van Doorn; Christian Janfelt; Uffe H Olesen; Merete Haedersdal; Catharina M Lerche
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

10.  Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma.

Authors:  Ashraf M Badawi; Mai Abdelraouf Osman
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.